Rajavithi Hospital
Bangkok, Thailand
NCT Number: NCT05639816
Retained CBD stone after ERCP is a common problem in clinical practice. This study aimed to evaluate the effect of saline irrigation of common bile duct after complete stone removal considered by ERCP in the reduction of residual CBD stone and the effect on clinical outcome.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Bangkok, Thailand
This study aimed to evaluate the effect of saline irrigation of common bile duct after complete stone removal considered by ERCP in the reduction of residual CBD stone and the effect on clinical outcome. Patients with CBD stone who received endoscopic stone removal were included after complete stone clearance was seen on occluded cholangiogram. One arm received saline irrigation of CBD at least 50 ml until clear effluent seen and another arm as control. Both group received endoscopic ultrasound to evaluation for residual stone and followed up for complication and outcome.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Normal saline irrigation of common bile duct after complete stone removal
Time frame: 1 day
Detected residual CBD stone by endoscoic ultrasound
Time frame: 1 day
procedural and non-procedural factors related to retained CBD stone
Time frame: 6 months
Complication associated with the procedure, hospital stay, and clinical outcome after the procedure
Department of Medical Services Ministry of Public Health of Thailand
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07345663
Biliary Tract Diseases, Calculi
Yantai, Shandong, China
View Trial DetailsNCT07058740
Biliary Tract Diseases, Calculi
Yantai, Shandong, China
View Trial DetailsNCT05945797
Bile Duct Diseases, Bile Duct Neoplasms
Gujranwala, Punjab Province, Pakistan
View Trial DetailsNCT06676241
Acute Pancreatitis (AP), Bile Duct Diseases
Moscow, Moscow Oblast, Russia
View Trial Details